🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology

Recruitingn/aAges 18 Years - 47 YearsAllCentre Hospitalier Universitaire, Amiens
NCT07312058 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity. Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment. However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission. This project aims to better understand the effectiveness, utilization, and psychological impacts of these strategies. This work is part of an effort to understand and evaluate fertility preservation practices implemented for women of reproductive age undergoing cancer treatment at the Amiens-Picardie University Hospital (CHU). Its objective is to document patient pathways, clinical decisions, techniques employed, and reproductive outcomes observed after remission, in order to identify potential areas fo

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women * Aged between 18 and 47 years * Diagnosed with cancer or hematological disorders requiring potentially gonadotoxic treatment * Having undergone a medical fertility preservation consultation * Followed at Amiens Picardie University Hospital (CHU Amiens Picardie) in the department of Reproductive Medicine * Currently in remission * Having expressed non-opposition to participation in the study Exclusion Criteria: * Absence of remission * Patients deprived of liberty by administrative or judicial decision, or placed under legal protection (guardianship or curators) * Decline to participate in the study
💊

What it tests

  • Not listed
📍

Where

1 site
CHU Amiens Picardie
Amiens, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy